LeadStory

10 News First

Medical ‘superglue’ trial shows promise for emphysema patients

10 News First · New
10 News First
10 News First
New

An Australian-led world first clinical trial using medical 'superglue' to improve life for emphysema patients is showing promising results, offering hope to those with no other treatment options.

Breakdown
  • Emphysema restricts lung function and often leaves patients with limited mobility.
  • Traditional valve treatments are not suitable for about 40% of patients due to holes between lung lobes. 31s
  • A team at the Royal Adelaide Hospital is trialing a glue injection to block these holes. 40s
  • Patient Dodie Briggs received the glue treatment and later benefited from valve therapy, improving her quality of life. 1m 5s
  • The trial is available in Adelaide, Brisbane, and Sydney for patients with no other treatment options. 1m 21s
Medical Research